Evidence map›Paper›PMID 34496085›Full record

Trial reportClinical oral implants research2021

Do postoperative antibiotics influence one-year peri-implant crestal bone remodelling and morbidity? A double-blinded randomized clinical trial.

Robert Durand, Issam Kersheh, Stéphanie Marcotte, Pierre Boudrias, Matthieu Schmittbuhl, Thierry Cresson, Nathalie Rei, Pierre H Rompré, René Voyer

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical oral implants research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Robert DurandDepartment of Oral Health, Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0000-0001-6526-606X
Issam KershehDepartment of Oral Health, Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.
Stéphanie MarcotteDepartment of Oral Health, Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.
Pierre BoudriasDepartment of Restorative Dentistry, Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.
Matthieu SchmittbuhlDepartment of Dental Medicine, Université de Montréal Hospital Center (CHUM), Montreal, QC, Canada.
Thierry CressonUniversité de Montréal Hospital Research Center (CR-CHUM), Montreal, QC, Canada.
Nathalie ReiDepartment of Stomatology, Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.
Pierre H RompréDepartment of Oral Health, Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.
René VoyerDepartment of Oral Health, Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.
Université de Montréal · CA

Funding

Université de Montréal
6 · The paper itself

Abstract

objectivesThe primary objective of this study was to assess whether giving postoperative antibiotics to healthy patients after straightforward platform-switched implant placement would influence peri-implant crestal bone levels and postoperative morbidity after 1 year.

methodsThirty-eight healthy individuals were recruited in this pilot, randomized, double-blinded, placebo-controlled clinical trial. The intervention group (n = 18) received two grams of amoxicillin one hour before implant placement followed by a 7 days postoperative regimen (500 mg tid). The control group (n = 20) took the same preoperative dose of amoxicillin and an identical placebo postoperatively. Mesial and distal peri-implant crestal bone levels were measured at baseline, four months and one year later with standardized periapical radiographs. Postoperative pain severity was assessed through self-administered questionnaires for 7 days. Surgery-associated morbidities were evaluated after one, three, 16 weeks and 1 year. Descriptive and bivariate analyses were used.

resultsThirty-seven participants completed the trial. At the one-year follow-up, the mean combined peri-implant crestal bone changes for the intervention (n = 18) and control (n = 19) groups were - 0.44 ± 0.41 mm and - 0.27 ± 0.56 mm, respectively. The difference between the groups (intervention-control) for mean combined crestal bone level changes was not statistically significant. There were no significant differences in surgery-associated morbidities between the intervention and control groups. The one-year implant survival rate was 100% in both groups.

conclusionsStudy results suggest that a routine postoperative antibiotic regimen for healthy patients undergoing straightforward platform-switched implant placement might not be necessary to prevent postoperative peri-implant bone loss and complications.

Indexed as

Alveolar Bone LossDental ImplantsAnti-Bacterial AgentsBone RemodelingDental Implantation, EndosseousHumansMorbidityAnti-Bacterial AgentsDental Implantsclinical researchclinical trialsdrug deliverypatient-centred outcomespharmacologywound healing

Identifiers

PMID34496085
PMCPMC9293101
OpenAlexW3198282529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.